Genscript said last December the Chinese government had accepted its application to run clinical trials for treatment of multiple myeloma. Photo: Shutterstock

Preclinical cancer treatment developer falls most in 6 weeks on share sales to raise US$302 million

The share placements to institutions will raise capital to fund research and manufacturing facilities

Topic |   Stocks

TOP PICKS

Genscript said last December the Chinese government had accepted its application to run clinical trials for treatment of multiple myeloma. Photo: Shutterstock
READ FULL ARTICLE